India’s ophthalmology sector is witnessing growing attention toward retinal conditions that can affect central vision and quality of life. Geographic atrophy (GA), an advanced form of dry age-related macular degeneration (AMD), involves the gradual degeneration of light-sensitive cells and supporting tissue in the macula. As awareness of retinal diseases develops and diagnostic capabilities advance, the need for specialized eye examinations, imaging technologies, and appropriate patient management is gaining importance. These developments are creating opportunities across ophthalmic diagnostics, healthcare services, and therapeutic research.

A comprehensive market assessment by Markntel Advisor reveals that the India Geographical Atrophy Market is valued at USD 0.96 Billion in 2026 and is projected to reach USD 1.79 Billion by 2032, registering a CAGR of 10.94% during 2026-2032. The India Geographical Atrophy Market Research Report identifies Optical Coherence Tomography Angiography (OCT-A) as the leading diagnosis-method segment. The study examines industry trends, diagnostic approaches, therapeutic developments, and opportunities shaping the sector during the forecast period.

Growing Attention to Retinal Health

Geographic atrophy is associated with advanced dry AMD and can progressively affect central vision. The condition is particularly relevant to eye-care providers because changes in the macula may influence activities that depend on detailed central vision. The National Eye Institute’s overview of age-related macular degeneration explains the stages and forms of AMD, including the effects of advanced disease on central vision. <Cite refs={["turn729541search0"]}/>

Growing attention to retinal health is encouraging the development of specialized ophthalmic services and diagnostic capabilities. Ophthalmologists use clinical examinations and retinal imaging to evaluate changes in the macula. Greater awareness among patients and healthcare professionals can also support timely eye assessments and continued monitoring where clinically appropriate.

OCT-A and Advances in Diagnostic Imaging

Diagnostic imaging plays an important role in the evaluation of retinal conditions. Optical Coherence Tomography Angiography (OCT-A) is an imaging technology that enables visualization of retinal and choroidal blood flow without the use of an injected contrast dye. Its applications in retinal assessment and research are contributing to the broader development of ophthalmic imaging capabilities.

As identified in the report, OCT-A represents the leading diagnosis-method segment in India’s geographical atrophy sector. Its position highlights the importance of advanced imaging technologies within the diagnostic landscape. Other approaches, including fundus autofluorescence and multifocal electroretinography, also contribute to the range of methods used to examine retinal structure and function.

A review published in Ophthalmology and Therapy, Imaging of Geographic Atrophy: A Practical Approach, discusses the role of different imaging modalities in identifying and monitoring geographic atrophy. It highlights the use of optical coherence tomography alongside other imaging techniques, while noting that diagnostic decisions require appropriate clinical assessment. <Cite refs={["turn538100search7"]}/>

Therapeutic Research Expands Industry Opportunities

Developments in therapeutic research are another important part of the geographical atrophy landscape. Research activity includes complement pathway inhibitors, gene therapy, regenerative approaches, and other investigational treatment strategies. These areas are attracting attention from pharmaceutical companies, biotechnology developers, research institutions, and ophthalmic specialists.

The National Eye Institute has documented the progress of research into treatments for geographic atrophy, including the development of therapies targeting the complement pathway. Its account of research supporting new dry AMD drugs illustrates how sustained scientific investigation can contribute to advances in treatment options. <Cite refs={["turn729541search10"]}/>

For industry participants, these developments create opportunities across drug research, clinical development, diagnostic services, and specialized eye-care delivery. Continued investigation into disease mechanisms and treatment approaches may also encourage collaboration between pharmaceutical companies, healthcare providers, and research organizations.

Healthcare Infrastructure and Commercial Potential

Hospitals, ophthalmic clinics, and specialty eye-care centers have important roles in the evaluation and management of retinal conditions. Access to trained specialists, advanced imaging equipment, and appropriate follow-up services can support the delivery of specialized ophthalmic care. Investment in diagnostic infrastructure and professional capabilities may therefore contribute to the development of this healthcare segment.

Companies operating in the sector can explore opportunities through diagnostic technology development, therapeutic innovation, research partnerships, and collaboration with healthcare institutions. As awareness of retinal conditions grows, accessible specialist services and reliable diagnostic capabilities will remain important considerations for the broader ophthalmology ecosystem.

Outlook

India’s geographical atrophy sector is positioned for continued development, supported by growing attention to retinal health, advances in diagnostic imaging, and ongoing therapeutic research. OCT-A’s leading position in the diagnosis-method category underscores the significance of specialized imaging within the industry. Progress across diagnostic technologies, pharmaceutical research, and ophthalmic care infrastructure is expected to shape future opportunities for healthcare providers, technology developers, and life-sciences companies.